“…However, the drug has been used in other situations with uncontrolled bleeding, including life-threatening obstetric hemorrhage [49,51,52]. Several case reports and reviews have described decreased blood product requirements in surgical and trauma patients with uncontrolled bleeding with the administration of rFVIIa [53,54]. The mechanism of action of rFVIIa is to augment the intrinsic clotting pathway by binding with tissue factor and directly activating factors IX and X [49,54].…”